Cover Image

Denys Drash Syndrome - A rare cause of SRNS, Male Pseudo-Hermaphroditism with Wilms Tumor

MOHAMED HASHIM M MAHAMOODULHASAN

Abstract


Back ground - Denys Drash syndrome is a very rare disorder characterized by gonadal dysgenesis,         nephropathy and wilms tumor. Case report - A 1 year 6 months boy presented with bilateral undescended testes, mid penile hypospadias and abdominal mass. On evaluation found to have wilms tumor, for which left nephrectomy was done. He was treated with chemo radiotherapy                             postoperatively.  Orchidopexy of both testes was done in stages following which he developed nephrotic                              syndrome-resistant to steroids. Thus Denys Drash syndrome was made out. He is on Mendoza regimen currently for SRNS. He has completed chemotherapy and is on regular follow up for Wilms tumor and SRNS and is now 3 years


Full Text:

PDF

References


Pelletier J, Bruening W, Kashtan CE et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys–Drash syndrome. Cell 1991; 67: 437–447

Armstrong JF, Pritchard-Jones K, Bickmore WA et al. The expression of the Wilms’ tumour gene, WT1, in the developing mammalian embryo. Mech Dev 1993;40: 85–97

Sharma PM, Yang X, Bowman M et al. Molecular cloning of rat Wilms’ tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res 1992; 52: 6407–6412

Kreidberg JA, Sariola H, Loring JM et al. WT-1 is required for early kidney development. Cell 1993; 74: 679–691

Guaragna MS, Soardi FC, Assumpção JG, Zambaldi Lde J, Cardinalli IA, Yunes JA, et al. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome. J Pediatr Hematol Oncol.

Aug 2010;32(6):486-8.

Breslow NE, Collins AJ, Ritchey ML, et al. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol . Nov 2005;174(5):1972-5.

,Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Bethesda, MD: Children's Oncology Group; Mar 2006.

Auber F, Lortat-Jacob S, Sarnacki S, et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg. Jan 2003;38(1):124-9; discussion 124-9.

Dome JS, Huff V. Wilms Tumor Overview. 2003 Dec 19 [Updated 2013 Sep 19]. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013.Available from: http://www.ncbi.nlm.nih.gov/books/NBK1294/

J Urol. 2005 Nov; 174(5):1972-5. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University